New York, NY, United States of America

Zhe Nie

This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Aconcagua Bio, Inc., Schrodinger, LLC. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhe Nie. Retrieved from https://idiyas.com/inventor/zhe-nie-e6raxyg4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zhe Nie: Innovator in Calcitonin and Amylin Receptor Modulation

Introduction

Zhe Nie is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the modulation of calcitonin and amylin receptor activities. His innovative work has the potential to impact the treatment of various medical conditions.

Latest Patents

Zhe Nie holds a patent for "Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity." This patent provides compounds designed to modulate calcitonin receptor and/or amylin receptor activity. Additionally, it includes pharmaceutical compositions comprising these compounds and outlines methods for treating diseases or disorders associated with these receptors.

Career Highlights

Zhe Nie is currently associated with Aconcagua Bio, Inc., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and a focus on addressing unmet medical needs.

Collaborations

Some of his notable coworkers include Hui Lei and Cui Li, who contribute to the collaborative environment at Aconcagua Bio, Inc. Their combined expertise enhances the potential for groundbreaking discoveries in their field.

Conclusion

Zhe Nie's contributions to the pharmaceutical industry, particularly through his patent on calcitonin and amylin receptor modulation, highlight his role as an influential inventor. His ongoing work at Aconcagua Bio, Inc. promises to lead to significant advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…